AGAP1 Activators comprises compounds that can indirectly influence the activity of AGAP1, a protein implicated in cellular processes like membrane trafficking and cytoskeletal dynamics. Since direct chemical activators of AGAP1 are not well-established, this list focuses on chemicals that modulate cellular signaling and trafficking pathways potentially related to AGAP1.
Actin cytoskeleton modifiers, like Jasplakinolide, and microtubule stabilizing agents, such as Paclitaxel, can impact the cytoskeletal dynamics where AGAP1 may play a role. Calcium ionophores (e.g., Ionomycin) and Rho kinase inhibitors (e.g., Y-27632) modulate intracellular signaling and actin dynamics, respectively, potentially influencing AGAP1-related functions. Phosphoinositide kinase inhibitors like Wortmannin and PI3K inhibitors such as LY294002 affect phosphoinositide metabolism, which is relevant to AGAP1's domain structure and potential functions. Similarly, modulators of GTPase Activating Proteins (GAPs) and inhibitors of specific small GTPases like Rac1 and Cdc42 can have cascading effects on cellular signaling pathways, thereby indirectly modulating AGAP1 activity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Jasplakinolide | 102396-24-7 | sc-202191 sc-202191A | 50 µg 100 µg | $184.00 $305.00 | 59 | |
Modifiers of the actin cytoskeleton can indirectly impact AGAP1 function in cytoskeletal dynamics. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
By influencing phosphoinositide metabolism, these inhibitors can affect pathways involving AGAP1. | ||||||
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $41.00 $74.00 $221.00 $247.00 $738.00 $1220.00 | 39 | |
Agents that affect microtubule dynamics might indirectly influence AGAP1 activity. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Calcium ionophores modulate intracellular calcium levels, potentially affecting AGAP1-related signaling. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Inhibitors of Rho kinase can impact actin dynamics, potentially affecting AGAP1 function. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Inhibitors of PI3K can affect signaling pathways relevant to AGAP1’s function. | ||||||